Trademark Overview
On Thursday, May 30, 2024, a trademark application was filed for REJUTRIA with the United States Patent and Trademark Office. The USPTO has given the REJUTRIA trademark a serial number of 98575938. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 30, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The REJUTRIA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders